Evidence map›Paper›PMID 42571305›Full record

ArticleCureus2026

Recurrent Stevens-Johnson Syndrome Following Inadvertent Re-exposure to Cotrimoxazole: A Preventable Adverse Drug Reaction.

Niva Doshi, Shruti Brahmbhatt

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Niva DoshiDepartment of Pharmacology, Shrimati Bhikhiben Kanjibhai Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth Deemed to be University, Vadodara, IND.
Shruti BrahmbhattDepartment of Pharmacology, Shrimati Bhikhiben Kanjibhai Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth Deemed to be University, Vadodara, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stevens-Johnson syndrome (SJS) is a severe cutaneous adverse drug reaction characterized by epidermal detachment and mucosal involvement. Cotrimoxazole is a well-known causative agent; however, recurrence following re-exposure remains underreported and preventable. We report a case of a 61-year-old female patient who presented with a burning sensation over the body, accompanied by superficial and crusted erosions over the lips and a few hyperpigmented macules on the chest for 10 days. On examination, a positive Nikolsky sign with <10% body surface area involvement was found, and a diagnosis of SJS was made. Notably, the patient had a documented history of SJS induced by cotrimoxazole five years earlier, with findings highly suggestive of recurrence following inadvertent re-exposure to the same causative agent. The disease severity was assessed using the SCORe of Toxic Epidermal Necrolysis (SCORTEN) criteria. The supportive treatment with dexamethasone, fluconazole, folic acid, and PCV transfusion was given, leading to gradual clinical improvement. This case highlights the importance of thorough drug-reaction history, avoidance of re-exposure to prevent recurrent severe cutaneous adverse reactions.

Indexed as

adverse drug reactioncotrimoxazolerecurrent stevens-johnson syndromescorten criteriawho-umc scale

Identifiers

PMID42571305
PMCPMC13451970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.